Bricanyl Turbuhaler: Uses, Dosage & Side Effects
A short-acting beta-2 agonist (SABA) bronchodilator delivered via dry powder inhaler for rapid relief of bronchospasm in asthma, COPD, and other obstructive airway diseases
Bricanyl Turbuhaler (terbutaline sulfate) is a short-acting inhaled bronchodilator used for rapid relief of acute breathing difficulties caused by asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, and emphysema. Terbutaline belongs to the class of selective beta-2 adrenergic agonists and works by relaxing the smooth muscles lining the airways, thereby widening the bronchial passages and making it easier to breathe. The Turbuhaler is a breath-activated dry powder inhaler that does not require coordination between pressing and inhaling, making it particularly user-friendly. Bricanyl Turbuhaler is intended for as-needed use to treat acute symptoms and should not be used as a substitute for regular anti-inflammatory controller therapy.
Quick Facts: Bricanyl Turbuhaler
Key Takeaways
- Bricanyl Turbuhaler contains terbutaline sulfate, a selective short-acting beta-2 agonist (SABA) that provides rapid bronchodilation within 3–5 minutes of inhalation, making it an effective rescue inhaler for acute asthma attacks and bronchospasm.
- It is intended for as-needed (PRN) use only – if you find yourself needing Bricanyl Turbuhaler more than twice a week, consult your doctor as this may indicate poorly controlled asthma requiring a change in your treatment plan.
- The Turbuhaler is a breath-activated dry powder inhaler that requires a deep, forceful inhalation to deliver the medication; no hand-breath coordination is needed, but correct technique is essential for full benefit.
- Common side effects include tremor and headache; these are usually mild, dose-related, and tend to resolve within the first 1–2 weeks of use as the body adjusts to the medication.
- Always continue using your prescribed preventer inhaler (e.g., inhaled corticosteroid) regularly, even when you feel well – Bricanyl Turbuhaler treats symptoms but does not address the underlying airway inflammation.
What Is Bricanyl Turbuhaler and What Is It Used For?
Bricanyl Turbuhaler contains the active substance terbutaline sulfate, a well-established medication that has been used in respiratory medicine for over four decades. Terbutaline is classified as a selective beta-2 adrenergic receptor agonist, commonly referred to as a short-acting beta-2 agonist or SABA. This class of medications represents one of the cornerstones of acute asthma management and is recommended by all major international guidelines, including those from the Global Initiative for Asthma (GINA), the British Thoracic Society (BTS), and the National Institute for Health and Care Excellence (NICE), as first-line rescue therapy for acute bronchospasm.
The primary action of terbutaline is to stimulate beta-2 adrenergic receptors located on the smooth muscle cells of the bronchial airways. When these receptors are activated, they trigger a cascade of intracellular signaling events. Specifically, the activation of the receptor stimulates the enzyme adenylyl cyclase, which increases the production of cyclic adenosine monophosphate (cAMP) within the smooth muscle cells. Elevated cAMP levels activate protein kinase A, which in turn phosphorylates several target proteins that result in relaxation of the bronchial smooth muscle. This process leads to bronchodilation – the widening of the airways – which reduces airway resistance and improves airflow to and from the lungs. In addition, terbutaline inhibits the release of inflammatory mediators from mast cells and facilitates mucociliary clearance, helping to mobilize and expectorate thick, sticky mucus from the airways.
The onset of bronchodilator action after inhalation of terbutaline via the Turbuhaler is rapid, typically occurring within 3 to 5 minutes. Peak effect is usually achieved within 30 to 60 minutes, and the duration of bronchodilation lasts approximately 4 to 6 hours, although this can vary between individuals and depending on the severity of the airway obstruction. This pharmacokinetic profile makes Bricanyl Turbuhaler ideally suited for quick relief of acute symptoms rather than long-term disease control.
Bricanyl Turbuhaler is indicated for the relief and prevention of bronchospasm in the following conditions:
- Bronchial asthma: For rapid relief of acute asthma symptoms including wheezing, shortness of breath, chest tightness, and coughing. According to GINA 2024 guidelines, SABAs such as terbutaline remain the recommended rescue medication for all asthma severity steps, although GINA now also recommends low-dose ICS-formoterol as an alternative reliever in mild asthma.
- Chronic obstructive pulmonary disease (COPD): For relief of acute bronchospasm episodes in patients with COPD. While long-acting bronchodilators are the mainstay of COPD maintenance therapy, SABAs remain important for on-demand symptom relief, particularly during acute exacerbations.
- Chronic bronchitis: For relief of airway obstruction and associated breathing difficulties in chronic bronchitis, particularly when reversible bronchospasm contributes to the symptoms.
- Emphysema: For symptomatic relief of bronchospasm in patients with emphysema, a condition characterized by irreversible damage to the alveoli (air sacs) of the lungs.
- Other obstructive airway diseases: For relief of bronchospasm associated with other respiratory conditions that cause airway narrowing, such as bronchiectasis or occupational lung disease.
It is important to understand that Bricanyl Turbuhaler is a reliever medication, not a controller or preventer. It provides symptomatic relief by opening the airways but does not treat the underlying inflammation that drives conditions like asthma. For patients with persistent asthma, regular use of an inhaled corticosteroid (ICS) or other anti-inflammatory controller medication is essential to manage the disease and reduce the risk of exacerbations. The World Health Organization (WHO) includes terbutaline on its Model List of Essential Medicines, underscoring its fundamental importance in global respiratory care.
The Turbuhaler is a multi-dose dry powder inhaler (DPI) developed by AstraZeneca. Unlike pressurized metered-dose inhalers (pMDIs), the Turbuhaler does not use a propellant gas. Instead, the medication is delivered as a fine powder that is drawn into the lungs by the patient’s own inspiratory effort. This breath-activated mechanism eliminates the need to coordinate pressing a canister with inhaling, which is a common difficulty with pMDIs. However, it does require a sufficiently forceful inhalation to ensure adequate drug deposition in the lower airways. Each Turbuhaler device contains 120 doses and includes a dose counter so patients can track their remaining doses.
What Should You Know Before Using Bricanyl Turbuhaler?
Contraindications
There is one absolute contraindication for Bricanyl Turbuhaler. The medication must not be used by individuals who have a known hypersensitivity (allergy) to terbutaline sulfate or to any of the excipients in the product, including lactose monohydrate. Allergic reactions to terbutaline are rare but can manifest as skin rash, itching, hives, or, in very rare cases, more severe allergic reactions. If you have experienced an allergic reaction to terbutaline or any other beta-2 agonist in the past, inform your doctor before using this product.
Warnings and Precautions
Certain medical conditions require special consideration before using Bricanyl Turbuhaler. Inform your doctor before starting treatment if any of the following conditions apply to you:
- Hyperthyroidism (overactive thyroid): Beta-2 agonists can exacerbate the cardiovascular effects associated with thyroid hormone excess, including tachycardia (rapid heart rate) and tremor. Close monitoring is advisable.
- Hypokalemia (low potassium levels): Terbutaline can cause a dose-dependent decrease in serum potassium levels through intracellular potassium shift. This effect may be potentiated by concomitant use of xanthine derivatives, corticosteroids, or diuretics. Severe hypokalemia can lead to muscle weakness, cardiac arrhythmias, and other complications. Regular monitoring of potassium levels may be recommended, particularly in patients at risk.
- Diabetes mellitus: Beta-2 agonists can increase blood glucose levels through stimulation of hepatic glycogenolysis and reduced peripheral glucose uptake. Patients with diabetes should monitor their blood sugar more frequently when using Bricanyl Turbuhaler and discuss any needed adjustments to their diabetes medication with their doctor.
- Cardiovascular disease: Terbutaline can increase heart rate and may potentially cause cardiac arrhythmias or exacerbate pre-existing cardiac conditions. Use with caution in patients with coronary artery disease, irregular heart rhythm, angina pectoris (chest pain), severe hypertension, or other significant cardiovascular disease.
- Narrow-angle glaucoma: While primarily a concern with nebulized anticholinergic agents, beta-2 agonists should be used with caution in patients with narrow-angle glaucoma. Inform your ophthalmologist about all respiratory medications you use.
If you notice that Bricanyl Turbuhaler is becoming less effective or that you need to use it more frequently than usual, contact your doctor promptly. Increasing reliever use is a well-recognized marker of deteriorating asthma control and may indicate that your underlying anti-inflammatory treatment needs to be adjusted. According to GINA guidelines, using a SABA more than twice per week (excluding pre-exercise use) suggests that asthma is not well controlled. Do not increase your dose of Bricanyl Turbuhaler without medical advice – instead, seek medical reassessment of your overall treatment plan.
Pregnancy and Breastfeeding
If you are pregnant, think you may be pregnant, or are planning to become pregnant, discuss the use of Bricanyl Turbuhaler with your doctor or midwife. Based on extensive clinical experience and available data, there are no known harmful effects associated with the use of inhaled terbutaline during pregnancy at standard therapeutic doses. However, as a general precaution, caution is advised during the first trimester when organogenesis occurs. It is important to note that uncontrolled asthma during pregnancy poses significant risks to both the mother and the developing baby, including pre-eclampsia, preterm delivery, low birth weight, and increased perinatal mortality. International guidelines, including those from GINA, BTS/SIGN, and the American College of Obstetricians and Gynecologists (ACOG), strongly recommend that asthma should be actively treated during pregnancy and that the risks of uncontrolled disease far outweigh any theoretical risk from SABA use.
Terbutaline passes into breast milk in small amounts. However, at therapeutic inhaled doses, the amount of terbutaline reaching the systemic circulation and subsequently the breast milk is very low, and it is unlikely to affect the nursing infant. Breastfeeding mothers can generally continue using Bricanyl Turbuhaler, but should discuss this with their healthcare provider.
Driving and Operating Machinery
Bricanyl Turbuhaler is not known to impair the ability to drive or operate machinery. No specific restrictions are required. However, if you experience side effects such as tremor or dizziness, exercise caution when performing these activities until you know how the medication affects you.
Lactose Content
Bricanyl Turbuhaler contains lactose monohydrate as an excipient, which serves as a carrier for the active substance in the dry powder formulation. Lactose is a type of sugar derived from milk. The amount of lactose in each inhaled dose is very small (less than 1 mg) and does not typically cause problems for individuals who are lactose intolerant. However, lactose can contain trace amounts of milk protein. In rare cases, patients with a confirmed allergy to milk protein (not lactose intolerance) may experience allergic reactions to these trace proteins. If you have been diagnosed with a milk protein allergy, consult your doctor before using this product.
How Does Bricanyl Turbuhaler Interact with Other Drugs?
Always inform your doctor, pharmacist, or other healthcare provider about all medications you are taking, have recently taken, or plan to take. This includes prescription medications, over-the-counter products, herbal supplements, and vitamin preparations. Some drugs can interact with terbutaline, potentially altering its effectiveness or increasing the risk of side effects.
Major Interactions
| Interacting Drug | Effect | Clinical Significance |
|---|---|---|
| Beta-blockers (propranolol, atenolol, metoprolol, sotalol, timolol eye drops) | Beta-blockers antagonize the bronchodilator effect of terbutaline and may precipitate severe bronchospasm | Non-selective beta-blockers (e.g., propranolol) are contraindicated in asthma. Cardioselective beta-blockers should be used with extreme caution. Even beta-blocker eye drops (e.g., timolol) can cause systemic effects. |
| Xanthine derivatives (theophylline, aminophylline) | Additive bronchodilator effect but increased risk of hypokalemia, tachycardia, and cardiac arrhythmias | Monitor serum potassium levels and heart rate. The combination may increase the risk of adverse cardiovascular effects. |
| Potassium-depleting diuretics (furosemide, hydrochlorothiazide, bendroflumethiazide) | Increased risk of hypokalemia through additive potassium-lowering mechanisms | Monitor serum potassium levels regularly, especially during acute severe asthma where hypoxia may further exacerbate the hypokalemic effect. |
Other Notable Interactions
| Interacting Drug | Effect | Clinical Significance |
|---|---|---|
| Other beta-2 agonists (salbutamol, formoterol, salmeterol) | Additive beta-adrenergic stimulation with increased risk of adverse effects | Avoid unnecessary concurrent use of multiple short-acting beta-2 agonists. Long-acting beta-2 agonists are typically combined with ICS, not other SABAs. |
| Corticosteroids (prednisolone, budesonide, beclometasone) | Systemic corticosteroids may potentiate the hypokalemic effect of beta-2 agonists | Monitor potassium levels, particularly during acute asthma exacerbations when high-dose systemic corticosteroids and frequent beta-2 agonist use are common. |
| Anticholinergics (ipratropium bromide, tiotropium) | Additive bronchodilator effect via complementary mechanisms | The combination of a beta-2 agonist with an anticholinergic bronchodilator is well established and therapeutically beneficial, particularly in COPD and acute severe asthma. |
| Certain anaesthetics (halothane, cyclopropane) | Halogenated anaesthetics may sensitize the myocardium to the effects of sympathomimetic amines, increasing the risk of arrhythmias | Inform your anaesthetist about all bronchodilator medications before any surgical procedure requiring general anaesthesia. |
This list does not cover all possible interactions. Always inform your healthcare provider about all medications and supplements you are using. If you are unsure about a potential interaction, consult your pharmacist or prescribing physician.
What Is the Correct Dosage of Bricanyl Turbuhaler?
Always use Bricanyl Turbuhaler exactly as your doctor has instructed. If you are unsure about your prescribed dose, consult your doctor or pharmacist. The general principle is that Bricanyl Turbuhaler should be used on an as-needed basis for acute symptom relief rather than on a fixed regular schedule. The goal is to use the lowest effective dose needed to control symptoms.
Adults
Standard Adult Dose
Strength: 0.25 mg per inhalation or 0.5 mg per inhalation
Dose: 1 inhalation (0.25 mg or 0.5 mg) as needed. A second inhalation may be taken if the first dose does not provide sufficient relief.
Maximum: Follow your doctor’s guidance. Typically, the total daily dose should not exceed what your physician has prescribed. If you consistently need more than the recommended amount, seek medical review.
Frequency: Use as needed for acute symptoms. Contact your doctor if you need to use it more than twice per week.
Children
Pediatric Dose
Age: Bricanyl Turbuhaler 0.25 mg may be prescribed for children, typically from around age 6 and older who can demonstrate adequate inhalation technique with a dry powder inhaler.
Dose: 1 inhalation (0.25 mg) as needed, as directed by the prescribing physician.
Important: Healthcare providers should ensure that children prescribed Bricanyl Turbuhaler can use the correct inhalation technique. Young children may not generate sufficient inspiratory flow for effective drug delivery from a dry powder inhaler. In such cases, alternative delivery systems (e.g., pMDI with spacer, or nebulized terbutaline) may be more appropriate.
Elderly Patients
Elderly Dose
No specific dose adjustment is routinely required for elderly patients. However, older adults may be more susceptible to the cardiovascular side effects of beta-2 agonists (particularly tachycardia and tremor) and should be monitored accordingly. Elderly patients should also be assessed for their ability to use the Turbuhaler device correctly, as reduced inspiratory capacity or dexterity issues may affect drug delivery.
Missed Dose
Because Bricanyl Turbuhaler is used on an as-needed basis, there is no concept of a “missed dose” in the traditional sense. Simply use the inhaler when you experience breathing difficulties or before situations that typically trigger bronchospasm (such as exercise or exposure to known triggers). Do not take a double dose to make up for a perceived missed dose.
Overdose
If you suspect you have taken significantly more Bricanyl Turbuhaler than prescribed, or if a child has accidentally used the inhaler, seek medical attention immediately. Contact your local emergency services or poison control center for advice.
Symptoms of terbutaline overdose may include:
- Nausea and vomiting
- Headache
- Restlessness, anxiety, and irritability
- Tremor (shaking)
- Fatigue and drowsiness
- Muscle cramps
- Palpitations (awareness of rapid or irregular heartbeat)
- Tachycardia (rapid heart rate)
- Hypokalemia (low blood potassium, which may cause muscle weakness and cardiac rhythm disturbances)
Over time, inhalation powder may accumulate in the Turbuhaler mouthpiece. This powder can become dislodged if the device is dropped or knocked. To minimize unnecessary exposure, rinse your mouth with water after each inhalation, which also helps reduce the risk of local side effects.
Preparing a new device: Remove the protective cap. Hold the Turbuhaler upright with the blue twist grip at the bottom. Twist the grip fully in one direction, then fully back – you should hear a click. Repeat this loading procedure once more. Your Turbuhaler is now primed and ready for first use.
Taking a dose: (1) Remove the cap. (2) Hold upright and twist the blue grip to load a dose (one full turn and back, listen for the click). (3) Breathe out gently, away from the device. (4) Place the mouthpiece between your teeth, close your lips tightly. (5) Breathe in deeply and forcefully through your mouth. (6) Remove from mouth and breathe out gently. (7) If a second inhalation is prescribed, repeat from step 2. (8) Replace the cap. (9) Rinse your mouth with water if possible.
Cleaning: Wipe the outside of the mouthpiece weekly with a dry cloth. Never use water or liquids.
Dose counter: The counter shows remaining doses in intervals of 10. When a red mark appears at the edge of the indicator window, approximately 20 doses remain. When “0” with a red background appears in the center, replace your Turbuhaler.
What Are the Side Effects of Bricanyl Turbuhaler?
Like all medicines, Bricanyl Turbuhaler can cause side effects, although not everybody experiences them. Most of the side effects associated with terbutaline are related to its beta-adrenergic activity and are dose-dependent – meaning they are more likely at higher doses. The majority of these effects are mild to moderate in severity and typically diminish or disappear within the first 1 to 2 weeks of treatment as the body adapts. If side effects persist, become troublesome, or if you notice any effects not listed here, contact your doctor or pharmacist.
Serious Side Effects
In rare cases, terbutaline may cause or worsen chest pain due to cardiac effects. If you experience chest pain, tightness, or pressure during or after using Bricanyl Turbuhaler, inform your doctor or nurse immediately. Do not stop using the medication unless your doctor instructs you to do so, as uncontrolled bronchospasm can also be dangerous.
Side Effect Frequency Overview
Very Common
Affects more than 1 in 10 users
- Tremor – Fine shaking, most noticeable in the hands. This is the most frequently reported side effect of all beta-2 agonists and is related to stimulation of beta-2 receptors in skeletal muscle. It is usually mild, dose-dependent, and resolves with continued use.
- Headache – Typically mild to moderate, often resolving within the first few days of treatment.
Common
Affects 1 in 10 to 1 in 100 users
- Hypokalemia – Low potassium levels in the blood, caused by intracellular potassium shift. Usually clinically insignificant at standard inhaled doses but may be relevant in patients taking concomitant potassium-depleting medications.
- Palpitations – Awareness of rapid or irregular heartbeat, resulting from beta-adrenergic stimulation of the heart. Usually benign and transient.
- Muscle cramps – Particularly in the legs and hands. May be related to hypokalemia or direct beta-2 stimulation of skeletal muscle.
Not Known
Frequency cannot be estimated from available data
- Restlessness and hyperactivity – Central nervous system stimulation may occasionally cause feelings of nervousness, agitation, or overactivity.
- Sleep disturbances – Insomnia or difficulty sleeping may occur, particularly if the medication is used close to bedtime.
- Cardiac arrhythmias – Irregular heart rhythms, including supraventricular tachycardia and atrial fibrillation, have been reported rarely.
- Paradoxical bronchospasm – In very rare cases, the medication may cause the airways to tighten rather than relax, producing a wheezing sound. If this occurs, stop using the inhaler and seek immediate medical attention.
- Nausea – Feeling sick to the stomach, usually mild and transient.
- Skin reactions – Pruritus (itching) and skin rash have been reported rarely.
Beta-2 agonists as a class are generally well tolerated when used at recommended inhaled doses. The side effect profile of terbutaline is comparable to that of salbutamol (albuterol), the other widely used SABA. Most side effects are pharmacologically predictable, dose-dependent, and reversible upon dose reduction or discontinuation. If you are concerned about any side effect, discuss it with your doctor – but do not stop using your rescue inhaler without medical advice, as untreated bronchospasm carries its own significant risks.
It is important to report suspected side effects after a medication has been approved. This enables continuous monitoring of the medicine’s benefit-risk balance. You can report side effects to your national medicines regulatory authority (e.g., the Medicines and Healthcare products Regulatory Agency [MHRA] in the UK, the European Medicines Agency [EMA] in Europe, or the FDA MedWatch program in the United States).
How Should You Store Bricanyl Turbuhaler?
Proper storage of your Bricanyl Turbuhaler is important to ensure the medication remains effective and safe throughout its shelf life. Follow these guidelines:
- Protective cap: Always keep the protective cap screwed onto the Turbuhaler when not in use. This protects the mouthpiece from dust, moisture, and accidental dose loading.
- Temperature: Store at room temperature, typically below 30°C (86°F). Avoid extremes of temperature. Do not refrigerate or freeze.
- Moisture: Because the Turbuhaler contains a dry powder formulation, exposure to moisture can compromise the medication. Keep the device in a dry environment and never wash the inside of the inhaler with water.
- Expiry date: Do not use the medication after the expiry date (EXP) printed on the device and outer packaging. The expiry date refers to the last day of that month.
- Keep out of reach of children: Store the inhaler where children cannot see or reach it.
- Disposal: Do not dispose of medicines in wastewater or household rubbish. Return unused or expired inhalers to your pharmacy for safe disposal. This helps protect the environment.
The sound you hear when shaking the Turbuhaler comes from a desiccant (drying agent) inside the device, not from the medication itself. Therefore, the rattling sound does not indicate how much medicine remains – always rely on the dose counter to track your remaining doses.
What Does Bricanyl Turbuhaler Contain?
Understanding the composition of your medication helps you identify potential allergens and ensure you are using the correct product.
Active Ingredient
Each delivered dose of Bricanyl Turbuhaler contains terbutaline sulfate, available in two strengths:
- 0.25 mg per inhalation – the standard strength
- 0.5 mg per inhalation – a higher strength option
Terbutaline sulfate is the pharmacologically active form of terbutaline. It is a white to off-white crystalline powder that is freely soluble in water. The sulfate salt form provides chemical stability and consistency in the dry powder formulation.
Excipient
The only excipient (inactive ingredient) in Bricanyl Turbuhaler is lactose monohydrate. Lactose serves as a carrier substance that helps the fine terbutaline powder flow properly through the inhaler device and aids in consistent dose delivery. As noted in the warnings section, lactose may contain trace amounts of milk protein, which is relevant for patients with milk protein allergy (distinct from lactose intolerance).
Packaging
Each Turbuhaler inhaler contains 120 doses. The device features an integrated dose counter that displays the number of remaining doses in increments of 10. The 0.25 mg/dose strength is available in packs of 1 inhaler (1 × 120 doses). The 0.5 mg/dose strength is available in packs of 1 or 2 inhalers (1 × 120 doses or 2 × 120 doses). Not all pack sizes may be marketed in every country.
The Turbuhaler device itself is a cylindrical white plastic inhaler with a blue rotating twist grip at the base and a shaped mouthpiece at the top. The mouthpiece is fixed and must not be removed. The blue twist grip is used to load each dose before inhalation. A protective cap covers the mouthpiece when the inhaler is not in use.
Frequently Asked Questions About Bricanyl Turbuhaler
Both Bricanyl Turbuhaler (terbutaline) and Ventolin (salbutamol/albuterol) are short-acting beta-2 agonists (SABAs) used as rescue inhalers for acute bronchospasm. They have similar efficacy, onset of action (3–5 minutes), and duration of effect (4–6 hours). The main differences lie in the active ingredient (terbutaline vs. salbutamol) and the delivery device. The Turbuhaler is a breath-activated dry powder inhaler that does not use propellant gas, while Ventolin is most commonly available as a pressurized metered-dose inhaler (pMDI). The choice between them often depends on patient preference, inhaler technique ability, and local prescribing practices. Your doctor will recommend the most suitable option for you.
Bricanyl Turbuhaler is designed for as-needed use to relieve acute symptoms, not for daily scheduled administration. If you find that you need to use your rescue inhaler every day, this is a strong signal that your underlying asthma or COPD is not adequately controlled. According to GINA guidelines, needing a SABA more than twice per week (excluding pre-exercise prophylaxis) indicates suboptimal asthma control. Contact your doctor as soon as possible for a review of your treatment plan – you may need to start or increase anti-inflammatory controller therapy, such as an inhaled corticosteroid.
The Turbuhaler has a built-in dose counter visible through a small window on the side of the device. When the inhaler is full, the counter shows 120. The counter decreases in increments of 10. When a red mark appears at the edge of the indicator window, approximately 20 doses remain. When “0” appears on a red background in the center of the window, the inhaler is empty and you should start using a new one. Important: the twist grip will continue to click even when the device is empty, and the rattling sound when you shake the device comes from a desiccant, not from the medication. Always rely on the dose counter.
Yes, Bricanyl Turbuhaler can be prescribed for children, typically from around age 6 onwards, provided they can demonstrate adequate inhalation technique. Dry powder inhalers like the Turbuhaler require a sufficiently forceful inhalation to draw the medication into the lungs. Younger children may not be able to generate the necessary inspiratory flow. Healthcare providers should always assess and verify correct inhalation technique in pediatric patients. For younger children who cannot use a DPI effectively, alternative delivery methods such as a pressurized metered-dose inhaler with a spacer device or nebulized terbutaline may be more appropriate.
Based on extensive clinical experience, inhaled terbutaline at recommended doses has not been associated with harmful effects during pregnancy. General caution is advised during the first trimester as a precautionary measure. It is important to emphasize that poorly controlled asthma during pregnancy poses significant risks to both the mother and baby, including preterm birth, low birth weight, and pre-eclampsia. All major international guidelines (GINA, BTS/SIGN, ACOG) recommend active treatment of asthma during pregnancy and confirm that the benefits of maintaining good asthma control with appropriate medications, including SABAs, outweigh the potential risks. Always discuss your asthma treatment with your doctor or midwife if you are pregnant or planning to become pregnant.
No. If you accidentally load the Turbuhaler more than once before taking your inhalation, you will still only receive one single dose. The loading mechanism prepares one measured dose at a time, and additional twisting does not stack doses. However, the dose counter will register each loading action, meaning it will count down by the number of times you loaded. So if you loaded twice and inhaled once, the counter will decrease by two even though you only received one dose. This means you may use up your inhaler slightly sooner than expected.
References
- Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Updated 2024. Available at: ginasthma.org
- European Medicines Agency (EMA). Bricanyl Turbuhaler – Summary of Product Characteristics (SmPC). AstraZeneca. Latest revision 2024.
- British Thoracic Society / Scottish Intercollegiate Guidelines Network (BTS/SIGN). British Guideline on the Management of Asthma. SIGN 158. Updated 2024.
- National Institute for Health and Care Excellence (NICE). Asthma: diagnosis, monitoring and chronic asthma management. NICE guideline [NG80]. Updated 2024.
- World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List. Geneva: World Health Organization; 2023.
- Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database of Systematic Reviews. 2013;(9):CD000052.
- Beasley R, Holliday M, Reddel HK, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. New England Journal of Medicine. 2019;380(21):2020-2030.
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2024 Report.
- Schatz M, Dombrowski MP. Asthma in pregnancy. New England Journal of Medicine. 2009;360(18):1862-1869.
- National Asthma Education and Prevention Program (NAEPP). Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Heart, Lung, and Blood Institute. 2007 (updated 2020).
Medical Editorial Team
Medical Content
iMedic Medical Editorial Team – Specialists in Respiratory Medicine and Clinical Pharmacology
Medical Review
iMedic Medical Review Board – Independent panel following WHO, GINA, and BTS/SIGN guidelines
Evidence Standard
Level 1A – Systematic reviews and meta-analyses of randomized controlled trials (GRADE framework)
Editorial Independence
No commercial funding. No pharmaceutical sponsorship. Independent medical editorial content.
Last medical review: | Published: